Work Here?
Industries
AI & Machine Learning
Biotechnology
Company Size
N/A
Company Stage
Seed
Total Funding
$29.2M
Headquarters
California
Founded
N/A
Chai Discovery develops AI foundation models that focus on predicting and reprogramming interactions between biochemical molecules, which are crucial for life. Their main product, Chai 1, is a multimodal model that can predict various molecular structures, such as proteins, small molecules, DNA, RNA, and covalent modifications. This model is available for free through a web interface, making it accessible for both academic researchers and pharmaceutical companies involved in drug discovery. Unlike many competitors, Chai Discovery emphasizes a user-friendly platform that allows clients to easily integrate AI into their research processes. The company's goal is to enhance the efficiency of research and development in the biotechnology and pharmaceutical sectors by providing powerful AI tools that facilitate molecular research.
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$29.2M
Above
Industry Average
Funded Over
1 Rounds
Industry standards
Health Insurance
Company Equity
Professional Development Budget
Wellness Program
(Bloomberg) -- Chai Discovery, an artificial intelligence biology startup founded six months ago, has raised nearly $30 million from heavyweights Thrive Capital and OpenAI to bring AI to drug discovery.Most Read from BloombergHow Americans Voted Their Way Into a Housing CrisisAfter a Record Hot Summer, Pressure Grows for A/C MandatesChicago Halts Hiring as Deficit Tops $1 Billion Through 2025UC Berkeley Gives Transfer Students a Purpose-Built Home on CampusChai develops AI foundation models that
Find jobs on Simplify and start your career today
Industries
AI & Machine Learning
Biotechnology
Company Size
N/A
Company Stage
Seed
Total Funding
$29.2M
Headquarters
California
Founded
N/A
Find jobs on Simplify and start your career today